Patents by Inventor Yves Chicheportiche

Yves Chicheportiche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND
    Publication number: 20100260761
    Abstract: The present invention relates to antibodies that bind Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.
    Type: Application
    Filed: June 5, 2006
    Publication date: October 14, 2010
    Applicants: BIOGEN, INC., THE FACULTY OF MEDICINE OF THE UNIV. OF GENEVA
    Inventors: Jeffrey Browning, Yves Chicheportiche
  • Tumor necrosis factor related ligand
    Patent number: 7695934
    Abstract: Nucleic acids that encode Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, are described.
    Type: Grant
    Filed: June 20, 2006
    Date of Patent: April 13, 2010
    Assignees: Biogen Idec MA Inc., The Faculty of Medicine of the University of Geneva
    Inventors: Jeffrey Browning, Yves Chicheportiche
  • Tumor necrosis factor related ligand
    Patent number: 7566769
    Abstract: Tumor Necrosis Factor Related Ligand (TRELL) polypeptides, a novel member of the tumor necrosis factor family (TNF) and compositions comprising them are disclosed.
    Type: Grant
    Filed: June 20, 2006
    Date of Patent: July 28, 2009
    Assignees: Biogen Idec MA Inc., The Faculty of Medicine of the University of Geneva
    Inventors: Jeffrey Browning, Yves Chicheportiche
  • TUMOR NECROSIS FACTOR RELATED LIGAND
    Publication number: 20060286111
    Abstract: Tumor Necrosis Factor Related Ligand (TRELL) polypeptides, a novel member of the tumor necrosis factor family (TNF) and compositions comprising them are disclosed.
    Type: Application
    Filed: June 20, 2006
    Publication date: December 21, 2006
    Applicants: BIOGEN IDEC MA INC., THE FACULTY OF MEDICINE OF THE UNIVERSITY OF GENEVA
    Inventors: Jeffrey Browning, Yves Chicheportiche
  • A TUMOR NECROSIS FACTOR RELATED LIGAND
    Publication number: 20060252122
    Abstract: Nucleic acids that encode Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, are described.
    Type: Application
    Filed: June 20, 2006
    Publication date: November 9, 2006
    Applicants: BIOGEN IDEC MA INC., THE FACULTY OF MEDICINE OF THE UNIVERSITY OF GENEV
    Inventors: Jeffrey Browning, Yves Chicheportiche
  • Antibodies specifically reactive with a tumor necrosis factor related ligand
    Patent number: 7087725
    Abstract: The present invention relates to Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: August 8, 2006
    Assignees: The Faculty of Medicine of the University of Geneva, Biogen Idec MA Inc.
    Inventors: Jeffrey Browning, Yves Chicheportiche